AGT and diabetic retinopathy: A study in diabetic retinopathy rat models demonstrated that inhibition of angiotensinogen (AGT) using siRNA-AGT reduced activation of the Ang II–ERK1/2 signaling pathway, promoted proliferation, and decreased apoptosis of retinal endothelial cells.